NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCTs031230064

Registered date:01/06/2023

Time course changes of O-17 water in the brain

Basic Information

Recruitment status Recruiting
Health condition(s) or Problem(s) studiedDementia
Date of first enrollment01/06/2023
Target sample size2
Countries of recruitment
Study typeInterventional
Intervention(s)MR imaging study with unapproved 0-17-labeled water

Outcome(s)

Primary OutcomeEvaluation of O-17 MRI imaging of normal brain based on intravenous injection of O-17-labeled water
Secondary Outcome1) Evaluation and analysis method of O-17 MR images of each imaging area (brain, eye, lumbar spine, liver, gall bladder) after intravenous injection of O-17-labeled water 2) Safety of intravenous injection of O-17-labeled water 3) Comparison of O-17 labeled water distribution in O-17 MRI images obtained from each imaging area

Key inclusion & exclusion criteria

Age minimum>= 18age old
Age maximum< 40age old
GenderBoth
Include criteria1.Healthy subject aged between 18 to 39 years old at informed consent 2.Subjects who weighs 60 kg or less 3.Subjects who provide written informed consent
Exclude criteria1.Subjects with a history of illness or surgery related to the brain, eye, lumbar spine, liver, or gall bladder 2.Subjects who are ill-qualified for MRI examination 3.Subjects who are claustrophobic and nyctophobia 4.Subjects who have serious hypersensitivity to drugs

Related Information

Contact

Public contact
Name Takayuki Obata
Address 4-9-1 Anagawa Inage-ku Chiba-shi Chiba, Japan Chiba Japan 263-8555
Telephone +81-43-206-3230
E-mail obata.takayuki@qst.go.jp
Affiliation National Institutes for Quantum Science and Technology
Scientific contact
Name Takayuki Obata
Address 4-9-1 Anagawa Inage-ku Chiba-shi Chiba, Japan Chiba Japan 263-8555
Telephone +81-43-206-3230
E-mail obata.takayuki@qst.go.jp
Affiliation National Institutes for Quantum Science and Technology